Marinesco Bodies in Neurodegeneration

Marinesco Bodies in Neurodegeneration

Overview

Marinesco bodies are intranuclear, eosinophilic inclusions found primarily in neurons of the substantia nigra pars compacta and other brain regions. First described by the Romanian neurologist Gheorghe Marinesco in the early 20th century, these inclusions are characterized by their spherical shape, basophilic appearance on hematoxylin and eosin staining, and electron-dense granular core structure. While classically associated with Parkinson's disease (PD), Marinesco bodies are also observed in aging brain, progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and various forms of dementia, making them important diagnostic and pathogenic markers in neurodegenerative research. [@wakabayashi2007]

Marinesco Bodies in Neurodegeneration

Overview

Marinesco bodies are intranuclear, eosinophilic inclusions found primarily in neurons of the substantia nigra pars compacta and other brain regions. First described by the Romanian neurologist Gheorghe Marinesco in the early 20th century, these inclusions are characterized by their spherical shape, basophilic appearance on hematoxylin and eosin staining, and electron-dense granular core structure. While classically associated with Parkinson's disease (PD), Marinesco bodies are also observed in aging brain, progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and various forms of dementia, making them important diagnostic and pathogenic markers in neurodegenerative research. [@wakabayashi2007]

Historical Background

The discovery of Marinesco bodies dates to the early 1900s when Gheorghe Marinesco, a pioneering Romanian neurologist and neuropathologist, first described intranuclear inclusions in the substantia nigra of patients with parkinsonism. His work established the morphological foundation for understanding these inclusions, though their pathogenesis remained enigmatic for decades. Subsequent electron microscopy studies in the 1960s and 1970s revealed the characteristic granular appearance and nuclear membrane association of these inclusions, distinguishing them from other neuronal inclusions such as Lewy bodies and neurofibrillary tangles. Modern immunohistochemical and molecular studies have begun to elucidate the protein composition of Marinesco bodies, revealing associations with ubiquitin, p62, and various nuclear proteins, suggesting roles in protein quality control and nuclear dysfunction in neurodegeneration. [@galpern2006]

Molecular Composition

Core Protein Components

Marinesco bodies are composed of several proteins that provide insights into their formation and significance:

• Ubiquitin: Marinesco bodies are consistently immunoreactive for ubiquitin, suggesting involvement of the ubiquitin-proteasome system in their formation or marking for degradation. This ubiquitin positivity distinguishes them from other inclusions and indicates accumulated misfolded or damaged nuclear proteins that fail to be cleared through normal cellular mechanisms.
• p62/SQSTM1: This autophagy adaptor protein co-localizes with Marinesco bodies, linking them to the autophagy-lysosomal pathway. p62 positivity suggests that impaired autophagy contributes to inclusion formation, and the presence of p62 indicates these inclusions may represent failed attempts at autophagic clearance of nuclear material.
• TDP-43: While primarily associated with ALS and FTD, TDP-43 has been detected in some Marinesco bodies, suggesting potential overlap in proteinopathy mechanisms across different neurodegenerative conditions. This finding indicates that nuclear RNA metabolism dysregulation may play a role in Marinesco body formation.
• Nuclear Pore Complex Components: Recent studies have identified proteins associated with the nuclear pore complex (NPC) in Marinesco bodies, including Nup62 and Nup88, suggesting that impaired nuclear transport may contribute to their formation. The nuclear envelope disruption hypothesis proposes that NPC dysfunction leads to accumulation of nuclear proteins in cytoplasmic inclusions.
• Heat Shock Proteins: Various heat shock proteins (HSPs), including HSP70 and HSP90, have been detected in Marinesco bodies, indicating involvement of the protein quality control machinery. These molecular chaperones may be recruited to inclusions in an attempt to refold or target damaged proteins for degradation.

Structural Features

Ultrastructurally, Marinesco bodies appear as spherical inclusions with a diameter ranging from 0.5 to 2 micrometers, located within the neuronal nucleus but occasionally appearing to indent the nuclear envelope. Electron microscopy reveals a granular, electron-dense core with associated fibrillary material, distinguishing them from the membranous profiles seen in Lewy bodies and the filamentous structure of neurofibrillary tangles. The inclusions typically lack a clear limiting membrane, suggesting they form through aggregation of soluble proteins rather than membrane-bound organelle sequestration. [@arai2003]

Anatomical Distribution

Primary Locations

Marinesco bodies demonstrate a characteristic distribution pattern in the human brain:

• Substantia Nigra Pars Compacta: The most frequent site of Marinesco body localization, particularly in the ventral tier neurons that are particularly vulnerable in Parkinson's disease. The prevalence increases with age and is higher in PD patients compared to age-matched controls, suggesting a pathogenic role in dopaminergic neuron loss.
• Locus Coeruleus: This norepinephrine-producing nucleus frequently contains Marinesco bodies, and the presence of inclusions here may contribute to the non-motor symptoms of PD, including autonomic dysfunction and depression. The locus coeruleus is also affected in other parkinsonian disorders, making this finding clinically relevant.
• Dorsal Motor Nucleus of the Vagus: The involvement of this nucleus in early PD suggests that Marinesco bodies may serve as early markers of neurodegeneration in the prodromal stage. The vagal nucleus is one of the earliest sites of Lewy body pathology according to Braak staging, and Marinesco bodies may follow a similar pattern. [@braak2003]
• Basal Forebrain Nuclei: Cholinergic neurons of the nucleus basalis of Meynert, which degenerate in both PD and Alzheimer's disease, occasionally contain Marinesco bodies, suggesting possible involvement in cholinergic dysfunction.
• Cerebellar Nuclei: Rare Marinesco bodies have been observed in the cerebellar deep nuclei, particularly in cases with cerebellar involvement in neurodegenerative processes.

Disease-Specific Patterns

The density and distribution of Marinesco bodies varies across different neurodegenerative conditions: [@kalia2015]

• Parkinson's Disease: Highest density in the substantia nigra, with age-matched controls showing fewer inclusions. The presence of Marinesco bodies in PD correlates with disease duration and may reflect ongoing nuclear dysfunction in surviving neurons.
• Progressive Supranuclear Palsy: Marinesco bodies are frequently observed in the substantia nigra and subthalamic nucleus, often co-existing with neurofibrillary tangles. The presence of both inclusion types suggests converging pathogenic mechanisms in tauopathies.
• Multiple System Atrophy: Marinesco bodies are found in the substantia nigra and pontine nuclei in MSA, where they may contribute to the characteristic neuronal loss in these regions. The presence of both Marinesco bodies and glial cytoplasmic inclusions suggests multiple pathogenic pathways in this disorder. [@stefanova2020]
• Aging Brain: Low numbers of Marinesco bodies are present in neurologically normal elderly individuals, raising questions about whether they represent a physiological aging marker or an early stage of subclinical neurodegeneration.

Pathogenic Mechanisms

Nuclear Pore Dysfunction

The nuclear pore complex (NPC) plays a critical role in maintaining nucleocytoplasmic compartmentalization and nuclear integrity. Evidence suggests that NPC dysfunction contributes to Marinesco body formation through several mechanisms:

Protein Quality Control Failure

The ubiquitin-positive nature of Marinesco bodies indicates involvement of the protein quality control systems:

Oxidative Stress and Mitochondrial Dysfunction

The substantia nigra is particularly vulnerable to oxidative stress due to several factors:

RNA Metabolism Dysregulation

The detection of TDP-43 in some Marinesco bodies suggests involvement of RNA metabolism pathways:

Clinical Correlation

Parkinson's Disease

The presence of Marinesco bodies in PD has several clinical implications:

• Disease Progression: Higher densities of Marinesco bodies correlate with longer disease duration, suggesting they accumulate as a consequence of ongoing neurodegeneration rather than serving as primary triggers.
• Clinical Phenotype: The anatomical distribution of Marinesco bodies may contribute to specific clinical features. Substantia nigra involvement correlates with motor symptoms, while locus coeruleus involvement may contribute to non-motor symptoms including depression and autonomic dysfunction.
• Neuropathological Staging: Marinesco bodies may serve as additional markers for neuropathological staging, complementing Lewy body distribution in understanding disease progression. [@braak2003]

Atypical Parkinsonism

In progressive supranuclear palsy and multiple system atrophy:

• Diagnostic Utility: The presence of Marinesco bodies alongside other pathological hallmarks helps distinguish between different parkinsonian disorders. The co-existence with neurofibrillary tangles in PSP and glial cytoplasmic inclusions in MSA provides diagnostic information.
• Disease Severity: Higher densities of Marinesco bodies correlate with more severe neuronal loss in affected regions, suggesting they may serve as markers of disease severity. [@jellinger2014]

Cognitive Decline

The presence of Marinesco bodies in regions important for cognition:

• Dementia with Lewy Bodies: Marinesco bodies are occasionally observed in cortical and limbic regions in DLB, potentially contributing to cognitive dysfunction through disruption of nuclear function in vulnerable neurons.
• Alzheimer's Disease: While less common than in parkinsonian disorders, Marinesco bodies are occasionally observed in AD, particularly in cases with comorbid Lewy body pathology.

Differential Diagnosis

Marinesco bodies must be distinguished from other neuronal inclusions:

Lewy Bodies

• Location: Primarily cytoplasmic, while Marinesco bodies are intranuclear
• Morphology: Classic concentric lamellar structure on EM vs. granular appearance of Marinesco bodies
• Composition: Alpha-synuclein positive vs. ubiquitin/p62 positive

Neurofibrillary Tangles

• Location: Primarily cytoplasmic (soma and dendrites)
• Structure: Paired helical filaments on EM
• Composition: Hyperphosphorylated tau positive

Bunina Bodies

• Size: Smaller (1-5 micrometers) than Marinesco bodies
• Location: Cytoplasmic
• Composition: Cystatin C and TDP-43 positive

Research Implications

Biomarker Potential

While not yet established as clinical biomarkers, Marinesco bodies offer research insights:

• Neuropathological Marker: Their presence provides postmortem confirmation of neurodegenerative processes
• Therapeutic Target: Understanding formation mechanisms may reveal novel therapeutic approaches
• Disease Models: Study of Marinesco body formation may inform cellular models of neurodegeneration

Future Directions

Several questions remain unresolved:

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
• [Multiple System Atrophy](/diseases/multiple-system-atrophy)
• [Tau Protein](/proteins/tau-protein)
• [TDP-43 Proteinopathy](/mechanisms/tdp-43-proteinopathy)

References